Veru Inc. (VERU)
NASDAQ: VERU · Real-Time Price · USD
2.530
-0.010 (-0.39%)
At close: Nov 18, 2025, 4:00 PM EST
2.500
-0.030 (-1.19%)
After-hours: Nov 18, 2025, 4:22 PM EST
Veru Inc. Market Cap
Veru Inc. has a market cap or net worth of $40.61 million as of November 18, 2025. Its market cap has decreased by -63.28% in one year.
Market Cap
40.61M
Enterprise Value
29.41M
1-Year Change
-63.28%
Ranking
Category
Stock Price
$2.53
Market Cap Chart
Since February 11, 1999, Veru Inc.'s market cap has increased from $17.00M to $40.61M, an increase of 138.87%. That is a compound annual growth rate of 3.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 37.20M | -60.92% |
| Dec 31, 2024 | 95.20M | 41.25% |
| Dec 29, 2023 | 67.40M | -84.17% |
| Dec 30, 2022 | 425.70M | -9.69% |
| Dec 31, 2021 | 471.40M | -22.24% |
| Dec 31, 2020 | 606.20M | 178.20% |
| Dec 31, 2019 | 217.90M | 148.46% |
| Dec 31, 2018 | 87.70M | 44.48% |
| Dec 29, 2017 | 60.70M | 112.98% |
| Dec 30, 2016 | 28.50M | -32.30% |
| Dec 31, 2015 | 42.10M | -62.74% |
| Dec 31, 2014 | 113.00M | -53.73% |
| Dec 31, 2013 | 244.20M | 18.60% |
| Dec 31, 2012 | 205.90M | 63.80% |
| Dec 30, 2011 | 125.70M | -19.63% |
| Dec 31, 2010 | 156.40M | 24.42% |
| Dec 31, 2009 | 125.70M | 30.39% |
| Dec 31, 2008 | 96.40M | 38.31% |
| Dec 31, 2007 | 69.70M | 85.87% |
| Dec 29, 2006 | 37.50M | -7.64% |
| Dec 30, 2005 | 40.60M | -11.74% |
| Dec 31, 2004 | 46.00M | -14.34% |
| Dec 31, 2003 | 53.70M | 88.42% |
| Dec 31, 2002 | 28.50M | 139.50% |
| Dec 31, 2001 | 11.90M | 80.30% |
View and export this data all the way back to 1999. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.77B |
| Johnson & Johnson | 481.14B |
| AbbVie | 417.81B |
| UnitedHealth Group | 281.78B |
| AstraZeneca | 277.65B |
| Novartis AG | 255.14B |
| Merck & Co. | 237.60B |
| Abbott Laboratories | 227.90B |